The daily dose: October 27, 2021

# Covaxin saga continues: The Technical Advisory Group reviewing Covaxin will reconvene on November 3rd for the final risk-benefit assessment. And thi

Comments

Popular posts from this blog

BJP’s victory in local body polls indicator of coming Assembly polls: Bommai

Should there be a lesson on Jinnah?: Karnataka K.S. Eshwarappa asks

Bengaluru: Bus conductor fails to return Rs 1; court orders BMTC to pay Rs 3K as compensation